FULC
Price
$7.25
Change
+$0.14 (+1.97%)
Updated
Jun 6 closing price
Capitalization
391.35M
60 days until earnings call
RVXCF
Price
$0.03
Change
-$0.00 (-0.00%)
Updated
Jun 4 closing price
Capitalization
8.31M
Interact to see
Advertisement

FULC vs RVXCF

Header iconFULC vs RVXCF Comparison
Open Charts FULC vs RVXCFBanner chart's image
Fulcrum Therapeutics
Price$7.25
Change+$0.14 (+1.97%)
Volume$388.35K
Capitalization391.35M
Resverlogix
Price$0.03
Change-$0.00 (-0.00%)
Volume$100
Capitalization8.31M
FULC vs RVXCF Comparison Chart
Loading...
FULC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FULC vs. RVXCF commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FULC is a Buy and RVXCF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (FULC: $7.25 vs. RVXCF: $0.03)
Brand notoriety: FULC and RVXCF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FULC: 65% vs. RVXCF: 1%
Market capitalization -- FULC: $391.35M vs. RVXCF: $8.31M
FULC [@Biotechnology] is valued at $391.35M. RVXCF’s [@Biotechnology] market capitalization is $8.31M. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FULC’s FA Score shows that 1 FA rating(s) are green whileRVXCF’s FA Score has 1 green FA rating(s).

  • FULC’s FA Score: 1 green, 4 red.
  • RVXCF’s FA Score: 1 green, 4 red.
According to our system of comparison, both FULC and RVXCF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FULC’s TA Score shows that 3 TA indicator(s) are bullish.

  • FULC’s TA Score: 3 bullish, 5 bearish.

Price Growth

FULC (@Biotechnology) experienced а +5.45% price change this week, while RVXCF (@Biotechnology) price change was +7.35% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

FULC is expected to report earnings on Aug 06, 2025.

RVXCF is expected to report earnings on May 14, 2025.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FULC($391M) has a higher market cap than RVXCF($8.31M). FULC YTD gains are higher at: 54.255 vs. RVXCF (-16.658). RVXCF has higher annual earnings (EBITDA): -8.09M vs. FULC (-8.94M). FULC has more cash in the bank: 227M vs. RVXCF (43K). FULC has less debt than RVXCF: FULC (8.11M) vs RVXCF (8.95M). FULC has higher revenues than RVXCF: FULC (80M) vs RVXCF (0).
FULCRVXCFFULC / RVXCF
Capitalization391M8.31M4,705%
EBITDA-8.94M-8.09M111%
Gain YTD54.255-16.658-326%
P/E RatioN/AN/A-
Revenue80M0-
Total Cash227M43K527,907%
Total Debt8.11M8.95M91%
FUNDAMENTALS RATINGS
FULC vs RVXCF: Fundamental Ratings
FULC
RVXCF
OUTLOOK RATING
1..100
2187
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
30
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8899
PRICE GROWTH RATING
1..100
3548
P/E GROWTH RATING
1..100
10095
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

FULC's Valuation (27) in the null industry is in the same range as RVXCF (30). This means that FULC’s stock grew similarly to RVXCF’s over the last 12 months.

FULC's Profit vs Risk Rating (100) in the null industry is in the same range as RVXCF (100). This means that FULC’s stock grew similarly to RVXCF’s over the last 12 months.

FULC's SMR Rating (88) in the null industry is in the same range as RVXCF (99). This means that FULC’s stock grew similarly to RVXCF’s over the last 12 months.

FULC's Price Growth Rating (35) in the null industry is in the same range as RVXCF (48). This means that FULC’s stock grew similarly to RVXCF’s over the last 12 months.

RVXCF's P/E Growth Rating (95) in the null industry is in the same range as FULC (100). This means that RVXCF’s stock grew similarly to FULC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
FULC
RSI
ODDS (%)
Bearish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
81%
Momentum
ODDS (%)
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 2 days ago
86%
Declines
ODDS (%)
Bearish Trend 17 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
81%
Aroon
ODDS (%)
Bullish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
FULC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DFUVX32.000.40
+1.27%
DFA US Large Cap Value III
OAKGX35.500.37
+1.05%
Oakmark Global Investor
RMFHX58.220.33
+0.57%
American Funds American Mutual R5E
PMVRX18.69N/A
N/A
Putnam Sustainable Future R
TMVAX25.29N/A
N/A
RBC Microcap Value A

FULC and

Correlation & Price change

A.I.dvisor indicates that over the last year, FULC has been loosely correlated with SLS. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if FULC jumps, then SLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FULC
1D Price
Change %
FULC100%
+1.97%
SLS - FULC
48%
Loosely correlated
-1.23%
ANNX - FULC
40%
Loosely correlated
+1.96%
VRDN - FULC
39%
Loosely correlated
+3.09%
MLTX - FULC
34%
Loosely correlated
-3.99%
ITOS - FULC
34%
Loosely correlated
-0.10%
More

RVXCF and

Correlation & Price change

A.I.dvisor tells us that RVXCF and TELIF have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RVXCF and TELIF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVXCF
1D Price
Change %
RVXCF100%
N/A
TELIF - RVXCF
22%
Poorly correlated
+1.31%
GRCE - RVXCF
21%
Poorly correlated
+0.34%
FULC - RVXCF
20%
Poorly correlated
+1.97%
NEUP - RVXCF
20%
Poorly correlated
-3.92%
SQZB - RVXCF
20%
Poorly correlated
-6.67%
More